在线血容量监测联合米多君治疗在维持性血液透析低血压病人中的临床观察
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Clinical observation on online blood volume monitoring combined with Midodrine for hypotensive patients undergoing maintenance hemodialysis
  • 作者:巩楠 ; 张学强 ; 韩晶 ; 张丽娜 ; 李慧君 ; 袁铮
  • 英文作者:GONG Nan;ZHANG Xueqiang;HAN Jing;ZHANG Lina;LI Huijun;YUAN Zheng;Blood Purification Section,The Central Hospital;
  • 关键词:在线血容量监测 ; 米多君 ; 血液透析 ; 低血压 ; 心率
  • 英文关键词:Online blood volume monitoring;;Midodrine;;Hemodialysis;;Hypotension;;Heart rate
  • 中文刊名:AHYY
  • 英文刊名:Anhui Medical and Pharmaceutical Journal
  • 机构:邯郸市中心医院血液净化科;
  • 出版日期:2019-01-31 16:14
  • 出版单位:安徽医药
  • 年:2019
  • 期:v.23
  • 基金:2017年度河北省医学科学研究重点课题计划(20171127)
  • 语种:中文;
  • 页:AHYY201902043
  • 页数:4
  • CN:02
  • ISSN:34-1229/R
  • 分类号:156-159
摘要
目的探讨在线血容量监测联合米多君治疗在维持性血液透析低血压病人中的临床疗效。方法选择2015年6月至2016年10月邯郸市中心医院收治的75例长期接受维持性血液透析低血压病人为研究对象,根据随机数字表法分为三组,每组25例。对照组实施在线血容量监测,观察组实施在线血容量监测联合米多君治疗,单用米多君组为单独使用米多君治疗。比较三组病人临床疗效,透析前及透析后平均动脉压和心率变化情况,并记录三组病人透析期间不适主诉、低血压发生率以及脱水量。结果观察组治疗总有效率为92.00%,高于对照组的68.00%和单用米多君组的80%,但差异无统计学意义(χ~2=4.500,P=0.105)。三组平均动脉压和心率水平相比,差异无统计学意义(P>0.05);治疗后,观察组各透析时间点平均动脉压水平均高于对照组及单用米多君组,差异有统计学意义(P<0.05);观察组透析时间2、3 h时间点心率低于对照组及单用米多君组,差异有统计学意义(P<0.05)。三组不适主诉率相比较,差异无统计学意义(χ~2=4.260,P=0.119)。观察组脱水量为(2.34±0.51)L高于对照组脱水量(1.83±0.34)L,两组比较差异有统计学意义(t=4.160,P<0.001),但观察组与单用米多君组脱水量(2.09±0.36)相比,差异无统计学意义(t=2.002,P=0.075)。结论对维持性血液透析低血压病人实施在线血容量监测联合米多君治疗,有利于降低低血压发生率,减少病人平均动脉压和心率变化,提高脱水量,减少病人不适感,有利于提高病人生活质量。
        Objective To explore the clinical efficacy of online blood volume monitoring combined with Midodrine for hypotensive patients undergoing maintenance hemodialysis.Methods Seventy-five hypotensive patients who had received long-term maintenance hemodialysis in The Central Hospital of Handan from June 2015 to October 2016 were selected as the research objects,and then according to the random number table method,these patients were assigned into three groups,with 25 cases in each group.The control group was given online blood volume monitoring,while the observation group was given online blood volume monitoring combined with Midodrine for treatment,and the Midodrine group was treated with Midodrine only.The clinical efficacy in the three groups,and changes of arterial pressure and heart rate before and after dialysis were compared,and complaints,incidence of hypotension and amount of dehydration during dialysis in the three groups were recorded.Results The total effective rate of treatment was 92.00% in the observation group,which was higher than 68.00% in the control group and was higher than 80.00% in the Midodrine group,but there was no statistically significant difference between the two groups(χ~2=4.500,P=0.105).There were no statistically significant differences in the mean arterial pressure and heart rate among the three groups(P>0.05).After treatment,the mean arterial pressure at different dialysis time points in the observation group was higher than that in the Midodrine group and the control group,and the difference was statistically significant(P<0.05).The heart rates at 2 h and 3 h of dialysis time points in the observation group were lower than those in the control group and the Midodrine group,and the differences were statistically significant(P<0.05).There was no significant difference in the rate of complaints among the three groups(χ~2=4.260,P=0.119).The amount of dehydration in the observation group was(2.34±0.51) L,which was higher than(1.83±0.34) L of the control group,and there was statistically significant difference between the two groups(t=4.160, P<0.001).There was no significant difference in the amount of dehydration between the observation group [(2.34±0.51) L] and the Midodrine group [(2.09±0.36) L](t=2.002,P=0.075).Conclusions For hypotensive patients undergoing maintenance hemodialysis,online blood volume monitoring combined with Midodrine can help to reduce the incidence of hypotension and the changes in mean arterial pressure and heart rate,increase the amount of dehydration,relieve their discomfort,and improve the quality of life among patients.
引文
[1] 余金波,刘中华,沈波,等.透析中低血压对血液透析患者长期预后的影响 [J].中华肾脏病杂志,2016,32(9):665-672.
    [2] 吴姝焜,杨鸿玲,王芳,等.人体成分分析仪监测在改善维持性血液透析患者透析低血压中的作用 [J].中国医药导刊,2016,18(1):28-29,31.
    [3] 黄敏,杨春琴.左卡尼汀对维持性血液透析低血压患者的临床疗效观察 [J].中国生化药物杂志,2016,36(4):83-85.
    [4] 潘珺.生脉注射液联合左卡尼汀对维持性血液透析低血压和微炎症状态影响 [J].国际泌尿系统杂志,2016,36(6):903-906.
    [5] 刘华.不同透析模式对中老年血液透析患者低血压的影响 [J].蚌埠医学院学报,2016,41(10):1370-1372.
    [6] 刘革非.左卡尼汀治疗血液透析中低血压的疗效及对症状和生活质量的影响 [J].中国医师杂志,2015,17(1):124-126.
    [7] 罗俊华,姜辉.生脉注射液在高龄维持性血液透析低血压患者中的应用价值及对ET-I、NO表达的影响 [J].现代中西医结合杂志,2015,24(15):1671-1673.
    [8] 崔龙,胡凤琪,秦永芳,等.血液透析滤过联合盐酸米多君治疗透析低血压的临床研究 [J].海南医学,2013,24(20):2986-2988.
    [9] 孙芳,刘婧,马丽洁,等.应用多频生物电阻抗法调节血液透析患者干体重对血压的影响 [J].北京医学,2011,33(2):120-123.
    [10] 李同妙,常立欣,耿同会,等.在线血容量监测在血液透析中的应用 [J].河北医科大学学报,2011,32(11):1347-1348.
    [11] 杨丽红,金炜,阮学青,等.临床血液透析在线血容量监测与干体重的调整及护理 [J].浙江医学,2014,36(9):821-823.
    [12] 赵丽萍,张飞鸿,周怡.在线血容量监测在血液透析患者数据信息系统的应用 [J].中国医学装备,2014,11(3):25-28.
    [13] 李红霞,邓文军,张春雨,等.直立后血压变化对盐酸米多君治疗儿童体位性心动过速综合征远期疗效的预测价值 [J].中华儿科杂志,2016,54(7):519-522.
    [14] 李锐钊,梁馨苓,黎思嘉,等.终末期糖尿病肾病患者血液透析中低血压和高血压的相关因素分析[J].中国血液净化,2014,13(7):502-505.
    [15] INRIG JK,MOLINA C,D'SILVA K,et al.Effect of low versus high dialysate sodium concentration on blood pressure and endothelial-derived vasoregulators during hemodialysis:a randomized crossover study[J].Am J Kidney Dis,2015,65(3):464-473.
    [16] PHILLIPS AA,WARBURTON DE,AINSLIE PN,et al.Regional neurovascular coupling and cognitive performance in those with low blood pressure secondary to high-level spinal cord injury:improved by alpha-1 agonist midodrine hydrochloride[J].J Cereb Blood Flow Metab,2014,34(5):794-801.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.